0001213900-22-028974.txt : 20220523 0001213900-22-028974.hdr.sgml : 20220523 20220523163051 ACCESSION NUMBER: 0001213900-22-028974 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220519 FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeLuca Teresa CENTRAL INDEX KEY: 0001685627 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38105 FILM NUMBER: 22952125 MAIL ADDRESS: STREET 1: 40 BURTON HILLS BOULEVARD, SUITE 500 CITY: NASHVILLE STATE: TN ZIP: 37215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 180 Life Sciences Corp. CENTRAL INDEX KEY: 0001690080 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813832378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 MENLO AVENUE, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-507-0669 MAIL ADDRESS: STREET 1: 830 MENLO AVENUE, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: KBL MERGER CORP. IV DATE OF NAME CHANGE: 20161115 4 1 ownership.xml X0306 4 2022-05-19 0 0001690080 180 Life Sciences Corp. ATNF 0001685627 DeLuca Teresa 3000 EL CAMINO REAL BLDG. 4, SUITE 200 PALO ALTO CA 94306 1 0 0 0 Common Stock 5000 D Common Stock 2500 I By Trust Common Stock 2500 I By Trust Common Stock 2500 I By Spouse Non-Qualified Stock Option (right to buy) 1.36 2022-05-19 4 A 0 21000 0.0 A 2032-05-19 Common Stock 21000 21000 D Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee. Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee. Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company. /s/ Teresa DeLuca 2022-05-23